The American Recovery and Reinvestment Act of 2009 invested $1.1 billion in federal initiatives to begin the important and necessary work of comparative effectiveness research (CER), a key building block in health care reform. However, whether CER can fulfill expectations of better quality, outcomes, and value in health care will depend on how it is implemented.
A forum hosted by the Engelberg Center for Health Care Reform and The Hamilton Project addressed many of the key questions surrounding CER and featured remarks from Sen. Max Baucus (D-Mont.) and Office of Management and Budget Director Peter Orszag. Three discussion papers released at the event focus on how research questions should be prioritized, what methods and data infrastructure are needed for CER, and how CER findings can be used to improve clinical and health policy decisions. A series of distinguished panels discussed the papers’ findings.
Participants took questions after each panel.
Agenda
Welcome
Mark B. McClellan
Director, Engelberg Center for Health Care Reform
Leonard D. Schaeffer Chair in Health Policy Studies
Featured Remarks: The Future of Comparative Effectiveness Research in the United States
The Honorable Max Baucus (D-Mont.)
United States Senate
Introductory Remarks
Robert E. Rubin
Co-Chair, Council on Foreign Relations
Former U.S. Treasury Secretary
Getting Our Money’s Worth from Patient-Centered Health Research
Peter R. Orszag
Director, Office of Management and Budget
Comparative Effectiveness Research: What It Is, What It’s Not, and Why We Need More
Kathleen Buto
Vice President, Health Policy, Government Affairs, Johnson & Johnson
Carolyn Clancy
Director, Agency for Healthcare Research and Quality
David Lansky
President and CEO, Pacific Business Group on Health
John Rother
Executive Vice President of Policy and Strategy, AARP
Moderator: Mark B. McClellan
Director, Engelberg Center for Health Care Reform
Leonard D. Schaeffer Chair in Health Policy Studies
Setting Priorities for Comparative Effectiveness Research (Discussion Paper 1)
Alan Garber
Director, Center for Primary Care and Outcomes Research, Stanford School of Medicine
David Meltzer
Associate Professor, University of Chicago School of Medicine
Mark Miller
Director, MedPAC
Elizabeth Nabel
Director, National Heart, Lung, and Blood Institute
Harold Sox
Past President, American College of Physicians
Strategies to Improve Comparative Effectiveness Research Methods and Data Infrastructure (Discussion Paper 2)
Robert Califf
Vice Chancellor for Clinical Research and Professor of Medicine, Duke University School of Medicine
Joshua Ofman
Vice President of Global Coverage & Reimbursement and Global Health Economics, Amgen
Sebastian Schneeweiss
Assistant Professor, Harvard Medical School
Ellen Sigal
Chair and Founder, Friends of Cancer Research
Sean Tunis
Director, Center for Medical Technology Policy
From Better Evidence to Better Care: Using Comparative Effectiveness Research to Guide Practice and Policy (Discussion Paper 3)
Marc Berger
Vice President, Global Health Outcomes, Eli Lilly & Co.
Steven Findlay
Senior Health Policy Analyst, Consumers Union
Scott Gottlieb
Resident Fellow, American Enterprise Institute for Public Policy Research
Sam Nussbaum
Executive VP and Chief Medical Officer, WellPoint
Steven Pearson
Director, Institute for Clinical and Economic Review
Closing Remarks
Mark B. McClellan
Director, Engelberg Center for Health Care Reform
Leonard D. Schaeffer Chair in Health Policy Studies
